InGeneron raises $20m in Series D for regenerative stem cell therapies

InGeneron said today that healthcare provider Sanford Health invested $20 million in the company’s Series D financing round.

The Houston, Texas.-based company said the funding will be used to support the clinical programs for its stem cell injections in patients with rotator cuff and venous ulcer tears.

“This significant investment demonstrates Sanford’s commitment to be an active participant in InGeneron as well as being our clinical trial site of choice,”  InGeneron president Ron Stubbers said in prepared remarks.

Get the full story at our sister site, Drug Delivery Business News.

The post InGeneron raises $20m in Series D for regenerative stem cell therapies appeared first on MassDevice.

from MassDevice http://ift.tt/2n6cear